 Home > Active Ingredient News > Antitumor Therapy > Prostate: Which is better for radical prostatectomy versus low-dose-rate brachytherapy in patients with intermediate-risk prostate cancer?

Prostate: Which is better for radical prostatectomy versus low-dose-rate brachytherapy in patients with intermediate-risk prostate cancer?

 Last Update: 2022-10-12
 Source: Internet
 Author: User

Tags

long stem funnel

long jaw calipers

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Prostate cancer (PCa) is the most commonly diagnosed malignant tumor in the United States and the second leading cause of cancer-related death in men, with both morbidity and mortality rates rising sharply in Japan in recent years

Recently, researchers from Japan published an article in Prostate that used a propensity score matching analysis to compare the long-term effects of radical prostatectomy (RP) and low-dose rate brachytherapy (LDR-BT) in patients with clinically localized, medium-risk prostate cancer (PCa

From October 2003 to March 2014, the researchers' facility treated a total of 1,241 patients with medium-risk PCa (RP:n=531; LDR-BT:n=710).

The findings found that the median follow-up time for RP was 108 months and LDR-BT was 99 months

Survival outcomes after RP and LDR-BT treatment

In summary, BCR cannot be used as a proxy indicator for survival comparison, mainly due to differences

Original Source:

Fumihiko Urabe， Kenta Miki， Takahiro Kimura et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

High Quality Resveratrol 99% powder 501-36-0 Shaanxi Dideu Medichem Co.Ltd

CAS No.: 501-36-0

Chemical Grade

$1/KG FOB

High purity Epirubicin hydrochloride 98% with best price 56390-09-1 and Epirubicin hydrochloride raw powder

CAS No.: 56390-09-1

Pharmacy Grade

$8.8-10/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.